Viemed Healthcare, Inc. (VMD)
NASDAQ: VMD · Real-Time Price · USD
9.15
-0.02 (-0.22%)
Nov 16, 2026, 4:00 PM EST - Market closed

Viemed Healthcare Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
310.37270.28224.26183.01138.83117.06
Revenue Growth
21.81%20.52%22.54%31.82%18.60%-10.85%
Cost of Revenue
132.2114.8291.0570.2354.1543.65
Gross Profit
178.17155.46133.2112.7884.6873.41
Selling, General & Admin
139.44120.24105.8587.8868.1654.89
Research & Development
2.183.023.072.782.72.11
Other Operating Expenses
-0.22-0.25-0.73-0.1-0.79-0.12
Operating Expenses
152.21133.62115.9597.8176.2862.88
Operating Income
25.9621.8317.2514.988.410.53
Interest Expense
-1.09-1.18-0.78-0.42-0.2-0.32
Interest & Investment Income
---0.490.94-
Earnings From Equity Investments
-----1.24
EBT Excluding Unusual Items
24.8620.6516.4715.049.1411.45
Merger & Restructuring Charges
-0.21-1.12-0.35---
Gain (Loss) on Sale of Investments
-0.16--0.95---
Gain (Loss) on Sale of Assets
-1.662.241.91-0.65-0.35-0.45
Other Unusual Items
---0.9-0.21.5
Pretax Income
22.8321.7716.1714.398.9912.5
Income Tax Expense
6.676.394.764.152.773.38
Earnings From Continuing Operations
16.1715.3811.4110.246.229.13
Minority Interest in Earnings
-0.54-0.44-0.14---
Net Income
15.6214.9311.2710.246.229.13
Net Income to Common
15.6214.9311.2710.246.229.13
Net Income Growth
14.78%32.57%9.98%64.63%-31.82%-71.06%
Shares Outstanding (Basic)
383939383939
Shares Outstanding (Diluted)
414141404041
Shares Change
-0.86%0.05%1.05%1.44%-2.15%0.38%
EPS (Basic)
0.410.380.290.270.160.23
EPS (Diluted)
0.380.370.280.250.160.22
EPS Growth
11.95%32.14%12.00%56.25%-27.27%-71.80%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
21.3811.931.3219.124.852.75
Free Cash Flow Per Share
0.530.290.030.470.120.07
Gross Margin
57.41%57.52%59.40%61.63%60.99%62.71%
Operating Margin
8.36%8.08%7.69%8.18%6.05%8.99%
Profit Margin
5.03%5.53%5.02%5.60%4.48%7.80%
Free Cash Flow Margin
6.89%4.41%0.59%10.45%3.49%2.35%
EBITDA
56.3950.4542.6236.8424.0321.84
EBITDA Margin
18.17%18.67%19.00%20.13%17.31%18.66%
D&A For EBITDA
30.4328.6125.3721.8615.6311.31
EBIT
25.9621.8317.2514.988.410.53
EBIT Margin
8.36%8.08%7.69%8.18%6.05%8.99%
Effective Tax Rate
29.20%29.36%29.44%28.82%30.79%27.01%
SEC Filings: 10-K · 10-Q